New Day Residential Treatment Program — Somerville, Massachusetts

New Day Residential Treatment Program is a clinical research site located in Somerville, Massachusetts, United States 02143.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

New Day Residential Treatment Program has participated in 1 clinical trials.

Therapeutic areas: Opioid Use Disorder, Maternal Drugs Affecting Fetus, Postpartum Mood Disturbance.

Sponsors: Massachusetts General Hospital.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Day Residential Treatment Program?

New Day Residential Treatment Program has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Day Residential Treatment Program conducted?

New Day Residential Treatment Program has 1 clinical trials on record. Their work covers Opioid Use Disorder, Maternal Drugs Affecting Fetus, Postpartum Mood Disturbance.

Is New Day Residential Treatment Program accredited by Crixeo Health?

New Day Residential Treatment Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Day Residential Treatment Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.